It's estimated that 50% of diabetic patients will have peripheral neuropathy as a complication within 3 years of the diabetes incidence \[14\], the goal of the study is to investigate this problem through the following objectives:
1. To measure the effect of using FREMS therapy in diabetic neuropathy in interventional group on the blood perfusion, neuropathy severity and quality of life after 10 sessions compared to baseline. 2. To measure the effect of using standard of care in diabetic neuropathy in control group on the blood perfusion, neuropathy severity and quality of life after 10 sessions compared to baseline. 3. To compare the results between both interventional and control group.
patients diagnosed with DM
patients age group above 40 years old.
patient diagnosed with peripheral neuropathy with symptoms lasts more than 3 months.
patients lower limb ischemia in duplex affected APSV.
patients with implant peacemakers, defibrillator, or neurostimulator.
pregnancy.
any severe disease prevent compliance to study procedures.
patients with disabilities prevent their commitment to sessions.